Literature DB >> 12696052

Cooperative fluctuations of unliganded and substrate-bound HIV-1 protease: a structure-based analysis on a variety of conformations from crystallography and molecular dynamics simulations.

Nese Kurt1, Walter R P Scott, Celia A Schiffer, Turkan Haliloglu.   

Abstract

The dynamics of HIV-1 protease, both in unliganded and substrate-bound forms have been analyzed by using an analytical method, Gaussian network model (GNM). The method is applied to different conformations accessible to the protein backbone in the native state, observed in crystal structures and snapshots from fully atomistic molecular dynamics (MD) simulation trajectories. The modes of motion obtained from GNM on different conformations of HIV-1 protease are conserved throughout the MD simulations. The flaps and 40's loop of the unliganded HIV-1 protease structure are identified as the most mobile regions. However, in the liganded structure these flaps lose mobility, and terminal regions of the monomers become more flexible. Analysis of the fast modes shows that residues important for stability are in the same regions of all the structures examined. Among these, Gly86 appears to be a key residue for stability. The contribution of residues in the active site region and flaps to the stability is more pronounced in the substrate-bound form than in the unliganded form. The convergence of modes in GNM to similar regions of HIV-1 protease, regardless of the conformation of the protein, supports the robustness of GNM as a potentially useful and predictive tool. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12696052     DOI: 10.1002/prot.10350

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  20 in total

1.  Rationale for more diverse inhibitors in competition with substrates in HIV-1 protease.

Authors:  Nevra Ozer; Celia A Schiffer; Turkan Haliloglu
Journal:  Biophys J       Date:  2010-09-08       Impact factor: 4.033

2.  iGNM: a database of protein functional motions based on Gaussian Network Model.

Authors:  Lee-Wei Yang; Xiong Liu; Christopher J Jursa; Mark Holliman; A J Rader; Hassan A Karimi; Ivet Bahar
Journal:  Bioinformatics       Date:  2005-04-28       Impact factor: 6.937

3.  The change of protein intradomain mobility on ligand binding: is it a commonly observed phenomenon?

Authors:  Semen O Yesylevskyy; Valery N Kharkyanen; Alexander P Demchenko
Journal:  Biophys J       Date:  2006-07-28       Impact factor: 4.033

4.  Interaction of anesthetics with open and closed conformations of a potassium channel studied via molecular dynamics and normal mode analysis.

Authors:  Satyavani Vemparala; Carmen Domene; Michael L Klein
Journal:  Biophys J       Date:  2008-02-29       Impact factor: 4.033

5.  Close correspondence between the motions from principal component analysis of multiple HIV-1 protease structures and elastic network modes.

Authors:  Lei Yang; Guang Song; Alicia Carriquiry; Robert L Jernigan
Journal:  Structure       Date:  2008-02       Impact factor: 5.006

6.  Temperature dependence of fluctuations in HIV1-protease.

Authors:  Kay Hamacher
Journal:  Eur Biophys J       Date:  2009-03-27       Impact factor: 1.733

7.  Exploring structural variability in X-ray crystallographic models using protein local optimization by torsion-angle sampling.

Authors:  Jennifer L Knight; Zhiyong Zhou; Emilio Gallicchio; Daniel M Himmel; Richard A Friesner; Eddy Arnold; Ronald M Levy
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2008-03-19

8.  Atomistic simulations of the HIV-1 protease folding inhibition.

Authors:  Gennady Verkhivker; Guido Tiana; Carlo Camilloni; Davide Provasi; Ricardo A Broglia
Journal:  Biophys J       Date:  2008-03-28       Impact factor: 4.033

9.  Conformational variation of an extreme drug resistant mutant of HIV protease.

Authors:  Chen-Hsiang Shen; Yu-Chung Chang; Johnson Agniswamy; Robert W Harrison; Irene T Weber
Journal:  J Mol Graph Model       Date:  2015-09-08       Impact factor: 2.518

10.  Mechanism of substrate recognition by drug-resistant human immunodeficiency virus type 1 protease variants revealed by a novel structural intermediate.

Authors:  Moses Prabu-Jeyabalan; Ellen A Nalivaika; Keith Romano; Celia A Schiffer
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.